(131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.
about
Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer.Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma.Radioactive iodine: An unappreciated threat to salivary gland function.Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population.
P2860
(131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
(131)I treatment for thyroid c ...... population-based cohort study.
@en
type
label
(131)I treatment for thyroid c ...... population-based cohort study.
@en
prefLabel
(131)I treatment for thyroid c ...... population-based cohort study.
@en
P2093
P2860
P1476
(131)I treatment for thyroid c ...... population-based cohort study.
@en
P2093
Cheng-Li Lin
Chia-Hung Kao
Kuan-Yin Ko
Wen-Sheng Huang
P2860
P2888
P304
P356
10.1007/S00259-015-3055-0
P577
2015-04-22T00:00:00Z